Drug makers accused of insulin price hike collusion
Some diabetes patients are begging doctors for free samples of life-saving insulin because of costs. Between 2002 and 2013, the price of insulin more than tripled, to more than $700 per patient. A federal lawsuit accuses three insulin manufacturers - Eli Lilly, Novo Nordisk and Sanofi - of conspiring to raise their prices. Anna Werner reports.